Michel Lagarde - Nov 13, 2025 Form 4 Insider Report for THERMO FISHER SCIENTIFIC INC. (TMO)

Role
Executive Vice President & COO
Signature
/s/ Melodie T. Morin, Attorney-in-Fact for Michel Lagarde
Stock symbol
TMO
Transactions as of
Nov 13, 2025
Transactions value $
-$1,578,914
Form type
4
Date filed
11/14/2025, 04:47 PM
Previous filing
Sep 2, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lagarde Michel Executive Vice President & COO 168 THIRD AVENUE, WALTHAM /s/ Melodie T. Morin, Attorney-in-Fact for Michel Lagarde 2025-11-14 0001518973

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMO Common Stock Options Exercise $1.18M +4.64K +19.75% $253.99 28.1K Nov 13, 2025 Direct
transaction TMO Common Stock Sale -$2.76M -4.64K -16.49% $594.42 23.5K Nov 13, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMO Stock Option (Right to Buy) Options Exercise $0 -4.64K -100% $0.00 0 Nov 13, 2025 Common Stock 4.64K $253.99 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $594.36 to $594.88, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2 The option vested in four equal installments on February 26, 2020, 2021, 2022, and 2023.